CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Factors associated with anti-tumor necrosis factor effectiveness to prevent postoperative recurrence in Crohn’s disease
Anthony Buisson, Lisa Cannon, Konstantin Umanskiy, Roger D. Hurst, Neil H. Hyman, Atsushi Sakuraba, Joel Pekow, Sushila Dalal, Russell D. Cohen, Bruno Pereira, David T. Rubin
Intest Res. 2022;20(3):303-312.   Published online August 4, 2021
DOI: https://doi.org/10.5217/ir.2021.00018

Excel Download

Factors associated with anti-tumor necrosis factor effectiveness to prevent postoperative recurrence in Crohn’s disease
Intestinal Research. 2022;20(3):303-312   Crossref logo
Link1 Link2 Link3

Anti–Tumor Necrosis Factor Therapy to Prevent Crohn's Disease Recurrence After Surgery
Clinical Gastroenterology and Hepatology. 2014;12(9):1503-1506   Crossref logo
Link1 Link2

Anti–Tumor Necrosis Factor Antibodies for Prevention of Crohn’s Disease Recurrence After Surgery: More Than a Hope
Clinical Gastroenterology and Hepatology. 2015;13(10):1856   Crossref logo
Link1 Link2

P502 Tumour necrosis factor antagonists are superior to anti-integrin and anti-IL-12/23 therapies for preventing postoperative recurrence in adult Crohn’s disease patients requiring postoperative therapy
Journal of Crohn's and Colitis. 2020;14(Supplement_1):S436-S437   Crossref logo
Link1 Link2

Anti-Tumor Necrosis Factor Nonresponders in Crohn’s Disease: Therapeutic Strategies
Digestive Diseases. 2009;27(3):351-357   Crossref logo
Link1 Link2

Postoperative Anti-TNF Therapy in the Management of Crohn's Disease
Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. 2015;201-205   Crossref logo
Link1 Link2

A159 ANTI-TUMOR NECROSIS FACTOR THERAPY PERSISTENCE IN PATIENTS WITH PERIANAL CROHN’S DISEASE AND LUMINAL CROHN’S DISEASE: A COMPARATIVE COHORT STUDY
Journal of the Canadian Association of Gastroenterology. 2021;4(Supplement_1):166-167   Crossref logo
Link1 Link2

Comparable outcomes of the consistent use versus switched use of anti- tumor necrosis factor agents in postoperative recurrent Crohn’s disease following ileocolonic resection
International Journal of Colorectal Disease. 2016;31(11):1751-1758   Crossref logo
Link1 Link2 Link3

Therapeutic Drug Monitoring Increases Drug Retention of Anti–Tumor Necrosis Factor Alpha Agents in Pediatric Patients With Crohn’s Disease
Inflammatory Bowel Diseases. 2019;   Crossref logo
Link1 Link2

Continued Postoperative Use of Tumor Necrosis Factor-α Inhibitors for the Prevention of Crohn’s Disease Recurrence
Gut and Liver. 2022;16(3):414-422   Crossref logo
Link1 Link2